-
Antibody production
How will monoclonal antibody production by hybridoma technology evolve in the coming decades
For the past decades, the hybridoma technology has allowed us to leverage potent and highly specific antibodies for therapy, research, and diagnostics. However, with the increasing demand for new antibody…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Antibody production
When you should choose to develop a peptide antibody for your project
Read more -
Antibody production
What Are the Hidden Challenges in Single B Cell Sorting You Need to Know?
Read more -
Antibody production
What stimulates antibody generation and how to leverage it for the design of effective immunization strategies
Read more
-
Blog
Which approach should you choose to get a species-specific veterinary monoclonal antibody? A decision guide
Read more -
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Read more -
Customers success stories
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more